Clinical Trial Update: Prevalence of Hyperprolactinemia in Systemic Scleroderma

View source ↗

Summary

This completed clinical trial update from University Hospital, Lille evaluates how common hyperprolactinemia is in patients with systemic sclerosis (scleroderma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: University Hospital, Lille | Conditions: Sclerosis, Systemic, Scleroderma | Status: COMPLETED